Viewing Study NCT05048134

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:34 AM

Ignite Modification Date: 2026-01-08 @ 4:04 AM

Study NCT ID: NCT05048134

Status: TERMINATED

Last Update Posted: 2024-09-19

First Post: 2021-08-31

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced Malignancies

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module